X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (66) 66
index medicus (60) 60
oncology (59) 59
male (58) 58
female (55) 55
middle aged (52) 52
aged (50) 50
chemotherapy (34) 34
adult (32) 32
cancer (27) 27
treatment outcome (25) 25
aged, 80 and over (23) 23
radiotherapy (22) 22
survival (19) 19
care and treatment (17) 17
therapy (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
radiology, nuclear medicine & medical imaging (15) 15
retrospective studies (15) 15
surgery (15) 15
disease-free survival (14) 14
prognosis (14) 14
neoplasm staging (13) 13
pancreatic neoplasms - drug therapy (13) 13
trial (13) 13
chemoradiation (12) 12
deoxycytidine - analogs & derivatives (12) 12
fluorouracil - administration & dosage (12) 12
gemcitabine (12) 12
liver neoplasms - drug therapy (12) 12
radiation (12) 12
survival rate (12) 12
abridged index medicus (11) 11
article (11) 11
capecitabine (11) 11
pancreatic neoplasms - pathology (11) 11
patients (11) 11
antineoplastic agents - therapeutic use (10) 10
chemoradiotherapy (10) 10
adenocarcinoma (9) 9
adenocarcinoma - drug therapy (9) 9
analysis (9) 9
antibodies, monoclonal, humanized (9) 9
bevacizumab (9) 9
carcinoma, hepatocellular - drug therapy (9) 9
fluorouracil (9) 9
hematology, oncology and palliative medicine (9) 9
hepatocellular carcinoma (9) 9
pancreatic cancer (9) 9
pancreatic neoplasms - mortality (9) 9
patient outcomes (9) 9
phase-ii (9) 9
radiology (9) 9
resection (9) 9
carcinoma, hepatocellular - pathology (8) 8
hepatoma (8) 8
liver neoplasms - pathology (8) 8
liver neoplasms - secondary (8) 8
medical research (8) 8
medicine, experimental (8) 8
mutation (8) 8
neoadjuvant therapy (8) 8
research (8) 8
antibodies, monoclonal - therapeutic use (7) 7
colorectal cancer (7) 7
deoxycytidine - administration & dosage (7) 7
liver neoplasms - mortality (7) 7
medicine & public health (7) 7
neoplasms (7) 7
pancreatic neoplasms - radiotherapy (7) 7
radiology and nuclear medicine (7) 7
survival analysis (7) 7
tumors (7) 7
adenocarcinoma - mortality (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
carcinoma (6) 6
chemoradiotherapy - methods (6) 6
cisplatin (6) 6
combination (6) 6
expression (6) 6
fluorouracil - analogs & derivatives (6) 6
fluorouracil - therapeutic use (6) 6
folfirinox (6) 6
follow-up studies (6) 6
health aspects (6) 6
kaplan-meier estimate (6) 6
long-term survival (6) 6
radiation-therapy (6) 6
radiotherapy dosage (6) 6
toxicity (6) 6
adenocarcinoma - pathology (5) 5
adenocarcinoma - secondary (5) 5
angiogenesis (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antineoplastic agents - adverse effects (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
biochemistry & molecular biology (5) 5
camptothecin - analogs & derivatives (5) 5
carcinoma, hepatocellular - mortality (5) 5
carcinomas (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 18, pp. 3027 - 3035
Journal Article
British Journal of Cancer, ISSN 0007-0920, 07/2014, Volume 111, Issue 3, pp. 430 - 436
Journal Article
Annals of Surgery, ISSN 0003-4932, 2015, Volume 261, Issue 1, pp. 12 - 17
Purpose: On the basis of the ACCORD trial, FOLFIRINOX is effective in metastatic pancreatic adenocarcinoma (PDAC), making it a rational choice for locally... 
Neoadjuvant therapy | Chemotherapy | FOLFIRINOX | PDAC | Surgery | Downstaging | Pancreas cancer | Pancreatic adenocarcinoma | 1423 PANCREATICODUODENECTOMIES | pancreatic adenocarcinoma | SURGEONS CONTRIBUTION | LONG-TERM SURVIVAL | MINIMAL POSTOPERATIVE COMPLICATIONS | ADENOCARCINOMA | PHASE-II | chemotherapy | neoadjuvant therapy | GEMCITABINE | CHEMORADIATION | pancreas cancer | RADIOTHERAPY | SINGLE-INSTITUTION EXPERIENCE | downstaging | surgery | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Humans | Middle Aged | Male | Pancreaticoduodenectomy | Chemoradiotherapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Neoadjuvant Therapy | Pancreatic Neoplasms - mortality | Retrospective Studies | Imaging, Three-Dimensional | Camptothecin - analogs & derivatives | Spiral Cone-Beam Computed Tomography | Pancreatic Neoplasms - pathology | Pancreatectomy | Treatment Outcome | Disease-Free Survival | Magnetic Resonance Imaging | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Adenocarcinoma - diagnostic imaging | Neoplasm Staging | Pancreatic Neoplasms - diagnostic imaging | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 153 - 158
Purpose Chemoradiation for anal cancer yields effective tumor control, but is associated with significant acute toxicity. We report our multi-institutional... 
Radiology | Hematology, Oncology and Palliative Medicine | IMRT | Anal cancer | Chemoradiation | Acute toxicity | CANAL CARCINOMA | RANDOMIZED-TRIAL | PHASE-II | MITOMYCIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | HIV-POSITIVE PATIENTS | SQUAMOUS-CELL CARCINOMA | TREATMENT TOLERANCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Tumor Burden - radiation effects | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Urogenital System - radiation effects | Gastrointestinal Tract - radiation effects | Male | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Squamous Cell - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Female | Retrospective Studies | Radiodermatitis - etiology | Lymphatic Irradiation - methods | Radiotherapy Dosage | Chemoradiotherapy - methods | Anus Neoplasms - diagnostic imaging | Actuarial Analysis - methods | Radiotherapy, Intensity-Modulated - methods | Treatment Outcome | Anus Neoplasms - pathology | Radiography | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Hematologic Diseases - etiology | Anus Neoplasms - radiotherapy | Carcinoma, Squamous Cell - secondary | Drug Substitution | Mitomycin - administration & dosage | Care and treatment | Radiotherapy | Nuclear radiation | Health aspects | Cancer | Toxicity | Canals | Radiation | Radiation therapy | Survival | Metastases | Chemotherapy | Immunosuppression | Age | Tumors | squamous cell carcinoma | Index Medicus | PATIENTS | AIDS VIRUS | RECTUM | BIOPSY | METASTASES | FEMALES | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | MEDICAL ESTABLISHMENTS | PLANNING | IMMUNOSUPPRESSION | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
Journal Article
Annals of Surgery, ISSN 0003-4932, 04/2019, Volume 269, Issue 4, pp. 733 - 740
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 48 - 54
Journal Article